Testing effectiveness (Phase 2)Looking for participantsNCT06422403
What this trial is testing
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Who this might be right for
Carcinoma, HepatocellularGastric AdenocarcinomaGastroEsophageal Cancer+3 more
National University Hospital, Singapore 360